Clinical effectiveness: The importance of psychosocial functioning outcomes

Journal of Affective Disorders

Volumn 132, Issue SUPPL. 1, 2011, Pages S9-

  Lam, Raymond W ^a   Filteau, Marie Josée ^b   Milev, Roumen ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Depressive disorders; Functioning; Measurement; Occupation; Quality of life; Social

Indexed keywords

ANXIETY; ATTENTION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DEPRESSION; GENERAL HEALTH QUESTIONNAIRE; HUMAN; MAJOR DEPRESSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; REVIEW; SHORT FORM 36; SOCIAL PSYCHOLOGY; VALIDATION STUDY; WORLD HEALTH ORGANIZATION;

EID: 79960290996     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.03.046     Document Type: Article

References (37)

1. P. Bech Social functioning: should it become an endpoint in trials of antidepressants? CNS Drugs 19 2005 313 324 (Pubitemid 40593602)
2. Brockow, T., Wohlfahrt, K., Hillert, A., Geyh, S., Weigl, M., Franke, T., Resch, K.L., Cieza, A., 2004. Identifying the concepts contained in outcome measures of clinical trials on depressive disorders using the International Classification of Functioning, Disability and Health as a reference.J. Rehabil. Med. 44 (Suppl 1), 49-55. (Pubitemid 39307111)
3. S.J. Coons, S. Rao, D.L. Keininger, and R.D. Hays A comparative review of generic quality-of-life instruments Pharmacoeconomics 17 2000 13 35 (Pubitemid 30072853)
4. J. Endicott, R.L. Spitzer, J.L. Fleiss, and J. Cohen The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance Arch. Gen. Psychiatry 33 1976 766 771
5. J. Endicott, J. Nee, W. Harrison, and R. Blumenthal Quality of life enjoyment and satisfaction questionnaire: a new measure Psychopharmacol. Bull. 29 1993 321 326 (Pubitemid 23311543)
6. H. Gilmour, and S.B. Patten Depression and work impairment Health Rep. 18 2007 9 22
7. R.Z. Goetzel, S.R. Long, R.J. Ozminkowski, K. Hawkins, S. Wang, and W. Lynch Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers J. Occup. Environ. Med. 46 2004 398 412 (Pubitemid 38469017)
8. P.E. Greenberg, R.C. Kessler, H.G. Birnbaum, S.A. Leong, S.W. Lowe, P.A. Berglund, and P.K. Corey-Lisle The economic burden of depression in the United States: how did it change between 1990 and 2000? J. Clin. Psychiatry 64 2003 1465 1475 (Pubitemid 41270106)
9. T.L. Greer, B.T. Kurian, and M.H. Trivedi Defining and measuring functional recovery from depression CNS Drugs 24 2010 267 284
10. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
11. M.J. Hilsenroth, S.J. Ackerman, and M.D. Blagys Reliability and validity of DSM-IV axis V Am. J. Psychiatry 157 2000 1858 1863
12. S.M. Hunt, and S.P. McKenna The QLDS: a scale for the measurement of quality of life in depression Health Policy 22 1992 307 319
13. S.H. Kennedy, B.S. Eisfeld, and R.G. Cooke Quality of life: an important dimension in assessing the treatment of depression? J. Psychiatry Neurosci. 26 Suppl 1 2001 S23 S28
14. R.C. Kessler, C. Barber, A. Beck, P. Berglund, P.D. Cleary, D. McKenas, N. Pronk, G. Simon, P. Stang, T.B. Ustun, and P. Wang The World Health Organization Health and Work Performance Questionnaire (HPQ) J. Occup. Environ. Med. 45 2003 156 174 (Pubitemid 36228294)
15. C. Koopman, K.R. Pelletier, J.F. Murray, C.E. Sharda, M.L. Berger, R.S. Turpin, P. Hackleman, P. Gibson, D.M. Holmes, and T. Bendel Stanford presenteeism scale: health status and employee productivity J. Occup. Environ. Med. 44 2002 14 20 (Pubitemid 34052802)
16. R.W. Lam, S.H. Kennedy, S. Grigoriadis, R.S. McIntyre, R. Milev, R. Ramasubbu, S.V. Parikh, S.B. Patten, and A.V. Ravindran Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy J. Affect. Disord. 117 Suppl 1 2009 S26 S43
17. R.W. Lam, E.E. Michalak, and L.N. Yatham A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder BMC Psychiatry 9 2009 78
18. A.C. Leon, M. Olfson, L. Portera, L. Farber, and D.V. Sheehan Assessing psychiatric impairment in primary care with the Sheehan Disability Scale Int. J. Psychiatry Med. 27 1997 93 105 (Pubitemid 27407503)
19. D. Lerner, B.C. Amick, W.H. Rogers, S. Malspeis, K. Bungay, and D. Cynn The work limitations questionnaire Med. Care 39 2001 72 85
20. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med. 3 2006 e442
21. P.E. McKnight, and T.B. Kashdan The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research Clin. Psychol. Rev. 29 2009 243 259
22. E.E. Michalak, G. Murray, A.J. Levitt, R.D. Levitan, M.W. Enns, R. Morehouse, E.M. Tam, A. Cheung, and R.W. Lam Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study Psychol. Med. 37 2007 727 736 (Pubitemid 46511097)
23. S.A. Montgomery, and M. Åsberg A new depression scale designed to be sensitive to change Br. J. Psychiatry 134 1979 382 389 (Pubitemid 9136500)
24. S.B. Patten, S.H. Kennedy, R.W. Lam, C. O'Donovan, M.J. Filteau, S.V. Parikh, and A.V. Ravindran Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: I. Classification, burden, and principles of management J. Affect. Dis. 117 2009 S5 S14
25. K. Sanderson, E. Tilse, J. Nicholson, B. Oldenburg, and N. Graves Which presenteeism measures are more sensitive to depression and anxiety? J. Affect. Disord. 101 2007 65 74 (Pubitemid 46879917)
26. P. Sobocki, B. Jonsson, J. Angst, and C. Rehnberg Cost of depression in Europe J. Ment. Health Policy Econ. 9 2006 87 98 (Pubitemid 44018376)
27. T. Stephens, and N. Joubert The economic burden of mental health problems in Canada Chronic Dis. Can. 22 2001 18 23 (Pubitemid 32537308)
28. The WHOQOL Group The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization Soc. Sci. Med. 41 1995 1403 1409
29. M.H. Trivedi, P.K. Corey-Lisle, Z. Guo, R.D. Lennox, A. Pikalov, and E. Kim Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning Int. Clin. Psychopharmacol 24 2009 133 138
30. H. Tuynman-Qua, F. de Jonghe, and S.P. McKenna Quality of life in depression scale (QLDS). Development, reliability, validity, responsiveness and application Eur. Psychiatry 12 1997 199 202 (Pubitemid 27246654)
31. A. Wade, K. Gembert, and I. Florea A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder Curr. Med. Res. Opin. 23 2007 1605 1614 (Pubitemid 47122170)
32. P.S. Wang, G.E. Simon, J. Avorn, F. Azocar, E.J. Ludman, J. McCulloch, M.Z. Petukhova, and R.C. Kessler Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial JAMA 298 2007 1401 1411 (Pubitemid 47481606)
33. J.E. Ware Jr., and C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I: conceptual framework and item selection Med. Care 30 1992 473 483
34. M.M. Weissman Social functioning and the treatment of depression J. Clin. Psychiatry 61 Suppl 1 2000 33 38 (Pubitemid 30124148)
35. M.M. Weissman, B.A. Prusoff, and W.D. Thompson Social adjustment by self-report in a community sample and in psychiatric outpatients J. Nerv. Ment. Dis. 166 1978 317 326 (Pubitemid 8368525)
36. J. Zajecka, A. Schatzberg, S. Stahl, A. Shah, A. Caputo, and A. Post Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial J. Clin. Psychopharmacol. 30 2010 135 144
37. M. Zimmerman, J.B. McGlinchey, M.A. Posternak, M. Friedman, N. Attiullah, and D. Boerescu How should remission from depression be defined? The depressed patient's perspective. Am. J. Psychiatry 163 2006 148 150